Welcome to our dedicated page for Kimball Electronics news (Ticker: KE), a resource for investors and traders seeking the latest updates and insights on Kimball Electronics stock.
Kimball Electronics, Inc. (Nasdaq: KE) generates a steady flow of corporate, financial, and strategic news as a global manufacturer providing Electronics Manufacturing Services (EMS) and Contract Manufacturing Organization (CMO) solutions. From its headquarters in Jasper, Indiana, and operations in the United States, China, Mexico, Poland, Romania, and Thailand, the company reports developments related to its automotive, medical, and industrial vertical markets.
News for KE commonly includes quarterly and annual earnings releases, where Kimball Electronics discusses net sales by vertical market, operating income, adjusted operating income, cash generation from operations, and portfolio changes such as the divestiture of its Automation, Test, and Measurement business. These updates often highlight trends in automotive programs like electronic power steering, body controls, advanced driver-assistance or automated driver assist systems, and electronic braking systems, as well as medical programs in areas such as sleep therapy and respiratory care, guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring.
Investors and observers can also expect news about strategic initiatives and capacity investments. The company has announced a new medical CMO facility in Indianapolis, describing it as a significant step in its medical strategy, and later detailed a ribbon-cutting event for an advanced medical manufacturing and innovation hub serving the medical and life sciences industries. Kimball Electronics has also communicated its intention to rebrand as Kimball Solutions, subject to approvals, reflecting what it describes as an expanded portfolio of capabilities and a solutions-driven approach.
Additional news items include participation in investor and industry conferences, announcements of annual meeting dates and proxy-related information, and leadership or governance updates reported through press releases and current reports on Form 8-K. For users following KE, this news stream provides context on the company’s operational performance, strategic focus on medical CMO activities, and its ongoing evolution within the EMS and manufacturing landscape.
Kimball Electronics, Inc. (Nasdaq: KE) will announce its first quarter fiscal year 2021 financial results on November 3, 2020, after the market closes. A conference call is scheduled for November 4, 2020, at 10:00 a.m. Eastern Time to discuss the results. Interested parties can access the call via 800-992-4934 or 937-502-2251 for international calls, using conference ID 7190817. The webcast will be available on Kimball's investor relations website.
Kimball Electronics (Nasdaq: KE) has announced a shift to a virtual-only 2020 Annual Meeting due to the ongoing COVID-19 pandemic. The meeting is scheduled for November 10, 2020, at 9:00 A.M. EST. Share Owners as of the record date September 8, 2020, are eligible to participate and vote. Attendees must enter a 16-digit control number to join the webcast. Voting is encouraged in advance, though allowed during the meeting. The company emphasizes its commitment to a high-performance culture and offers diverse manufacturing solutions globally.
Kimball Electronics (NASDAQ: KE) has appointed Douglas A. Hass as Associate General Counsel and Assistant Secretary, effective immediately. Previously serving as General Counsel for Lifeway Foods, Mr. Hass brings extensive legal expertise and a decade of experience in the technology sector. John Kahle, VP and General Counsel, noted that Mr. Hass's leadership skills are crucial as the company continues to grow since becoming a public entity in 2014. Kimball Electronics operates globally, providing manufacturing solutions across various industries, focusing on quality and ethical behavior.
Kimball Electronics reported its fourth-quarter financial results for fiscal year 2020, revealing net sales of $286 million, a decline of 10% year-over-year. The company experienced a net loss of $1.3 million, which includes a non-cash goodwill impairment charge of $6.9 million. However, adjusted net income was $8.5 million, with a loss per share of $0.05 and an adjusted diluted EPS of $0.34. The company generated robust operating cash flows of $21.5 million.
Sales in the medical vertical surged 23% year-over-year, while automotive sales fell 43% due to COVID-19 disruptions.
Kimball Electronics (NASDAQ: KE) will report its Q4 fiscal year 2020 financial results on August 18, 2020, post-market. A conference call to discuss these results is scheduled for August 19, 2020, at 10:00 a.m. ET. Interested parties can join via telephone or online webcast. The call will also be archived for later access. Kimball Electronics is a leading provider of manufacturing solutions for various industries, operating globally in multiple countries.
Kimball Electronics, Inc. (NASDAQ: KE) announced internal promotions aimed at accelerating its strategic growth on June 30, 2020. Effective July 1, Steve Korn has been appointed President of Global Electronics Manufacturing Services (EMS) Operations, while Lee Kemper becomes Vice President of Diversified Contract Manufacturing Services (DCMS). CEO Donald D. Charron highlighted their leadership and contributions, noting Korn's role in achieving over $1 billion in sales. The restructuring consolidates operations under Korn to enhance the company's focus on its core EMS business and Industry 4.0 strategy.
Kimball Electronics (NASDAQ: KE) reported third-quarter net sales of $294 million, down 6% year-over-year. The company posted a net income of $6.3 million with diluted earnings per share (EPS) of $0.25. Cash flows from operations were strong at $12.0 million, improving from a cash outflow of $14.6 million in the same quarter last year. They experienced a decline in sales across several verticals, particularly a 12% drop in medical sales, but anticipate increased demand for medical assemblies related to respiratory care. The company reported a return on invested capital of 7.1%.